As of July 2014, the market cap for Nektar Therapeutics (NKTR) is $1,398,016,781.01.
As of July 2014, the market cap for Pain Therapeutics (PTIE) is $221,187,227.90.
As of July 2014, the market cap for Celsus Therapeutics Plc (CLTX) is $22,728,791.75.
As of July 2014, the market cap for Cesca Therapeutics Inc. (KOOL) is $46,374,337.28.
As of July 2014, the market cap for Cymabay Therapeutics Inc. (CBAY) is $60,087,011.22.
As of July 2014, the market cap for Cytori Therapeutics Inc (CYTX) is $162,990,470.16.
As of July 2014, the market cap for Corcept Therapeutics Incorporated (CORT) is $246,180,984.24.
As of July 2014, the market cap for Regulus Therapeutics Inc. (RGLS) is $292,658,548.50.
As of July 2014, the market cap for Repros Therapeutics Inc. (RPRX) is $338,146,111.68.
As of July 2014, the market cap for Anika Therapeutics Inc. (ANIK) is $692,805,016.80.
As of July 2014, the market cap for United Therapeutics Corporation (UTHR) is $4,429,004,268.71.
As of July 2014, the market cap for Galectin Therapeutics Inc. (GALT) is $300,581,395.80.
As of July 2014, the market cap for Karyopharm Therapeutics Inc. (KPTI) is $1,088,116,963.44.